Difgen Pharmaceuticals Private Limited - Company Profile

It is a research & development private limited company based in Balanagar, Telangana, India, established in 2022.
2022 Balanagar, Telangana, India Active
Last Updated:
Access Report
About Difgen Pharmaceuticals Private Limited

Difgen Pharmaceuticals Private Limited, a active private limited company, was established on 06 May 2022 in Balanagar, Telangana, India. Engaging in research & development within the professional, scientific and technical sector, it holds CIN: U72100TG2022PTC162383. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.

It upholds a compliant status. Employing 92 professional, Its leadership includes Valiveti Brahmaji (Additional Director), Krishna Chandrasekaran (Director), Zubin Keki Gandhi (Director). Past directors included Krishna Chandrasekaran, Satya Saibaba Manchala, Zubin Keki Gandhi. It holds ₹5.09 M open charges and no settled loans. Its latest AGM occurred on 11 September 2025, with the balance sheet filed on 31 March 2025. It is based at 5- 35/189A, Survey No. 390 Prashanthi Nagar, 100 Feet Road, Ie Kukatpally, Rangareddy,, Balanagar, Telangana, 500072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U72100TG2022PTC162383

  • Registration Number

    162383

  • Incorporation Date

    06 May 2022

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹1.00 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 1.00 Cr
  • Company Age 3 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 5.09 M
  • Revenue Growth **** 261.76%
  • Profit Growth **** -221.76%
  • Ebitda **** -311.97%
  • Net Worth -747.61%
  • Total Assets **** 262.20%
Company report

Difgen Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Difgen Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Difgen Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Valiveti Brahmaji Additional Director 21 Jan 2025 Current
Krishna Chandrasekaran Director 24 Jul 2023 Current
Zubin Keki Gandhi Director 24 May 2022 Current
Yatin Kirtanlal Desai Director 24 May 2022 Current
Punit Chunilal Thakrar Director 04 Jul 2022 Current
Santhanakrishnan Srinivasan Director 15 Nov 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 14 Nov 2023 Past
Pramod Abcsdd Director 20 Jul 2022 Past
Pramod Abcsdd Additional Director 14 Nov 2023 Past
Pramod Abcsdd Additional Director 14 Nov 2023 Past
Pramod Abcsdd Additional Director 14 Nov 2023 Past
Pramod Abcsdd Additional Director 14 Nov 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Difgen Pharmaceuticals.

Difgen Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 261.76% increase. The company also saw a substantial fall in profitability, with a 221.76% decrease in profit. The company's net worth observed a substantial decline by a decrease of 747.61%.

Difgen Pharmaceuticals revenue growth over time
Difgen Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 261.76%
*******
*******
*******
*******
Revenue from Operations
*******
 261.72%
*******
*******
*******
*******
Total Assets
*******
 262.20%
*******
*******
*******
*******
Profit or Loss
*******
 -221.76%
*******
*******
*******
*******
Net Worth
*******
 -747.61%
*******
*******
*******
*******
EBITDA
*******
 -311.97%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Difgen Pharmaceuticals?

In 2024, Difgen Pharmaceuticals had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹5,094,630.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 0.51 Cr
Latest Charge Details
Date Lender Amount Status
28 May 2024 Hdfc Bank Limited ₹2.69 M Open
25 Jul 2022 Hdfc Bank Limited ₹2.41 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Difgen Pharmaceuticals?

Difgen Pharmaceuticals has a workforce of 92 employees as of Mar 24, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Difgen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Difgen Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Difgen Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Difgen Pharmaceuticals Private Limited last Annual general meeting of members was held on 11 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Difgen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Director Appointment

    Narasimhan Sridhar Nagaarjun was appointed as a Additional Director was appointed as a Additional Director on 13 Feb 2025 & has been associated with this company since 1 year 3 days . was recorded as a recent event.

  • Director Appointment

    The activity Valiveti Brahmaji was appointed as a Additional Director was appointed as a Additional Director on 21 Jan 2025 & has been associated with this company since 1 year 26 days . was completed.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 0.27 Cr with Charge ID 100937260 was registered on 28 May 2024. was completed.

  • Director Appointment

    Krishna Chandrasekaran was appointed as a Director was appointed as a Director on 24 Jul 2023 & has been associated with this company since 2 years 6 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Difgen Pharmaceuticals Private Limited?

The CIN of Difgen Pharmaceuticals Private Limited is U72100TG2022PTC162383.

Where is Difgen Pharmaceuticals Private Limited headquartered?

Difgen Pharmaceuticals Private Limited is headquartered at 5- 35/189A, Survey No. 390 Prashanthi Nagar, 100 Feet Road, Ie Kukatpally, Rangareddy,, Balanagar, Telangana, 500072.

When was Difgen Pharmaceuticals Private Limited incorporated?

Difgen Pharmaceuticals Private Limited was incorporated on 06 May 2022.

Who are the current directors of Difgen Pharmaceuticals Private Limited?

The current directors of Difgen Pharmaceuticals Private Limited are

What is the primary industry of Difgen Pharmaceuticals Private Limited?

The primary industry of Difgen Pharmaceuticals Private Limited is Professional, Scientific And Technical.

Is Difgen Pharmaceuticals Private Limited a listed company?

Difgen Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Difgen Pharmaceuticals Private Limited?

The authorized capital of Difgen Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.

What is the compliance status of Difgen Pharmaceuticals Private Limited?

The compliance status of Difgen Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available